Lack of VMP1 Impairs Hepatic Lipoprotein Secretion and Promotes Nonalcoholic Steatohepatitis

Xiaoxiao Jiang,Sam Fulte,Fengyan Deng,Shiyuan Chen,Yan Xie,Xiaojuan Chao,Xi C. He,Yuxia Zhang,Tiangang Li,Feng Li,Colin McCoin,E. Matthew Morris,John Thyfault,Wanqing Liu,Linheng Li,Nicholas O. Davidson,Wen-Xing Ding,Hong-Min Ni
DOI: https://doi.org/10.1016/j.jhep.2022.04.010
IF: 25.7
2022-04-01
Journal of Hepatology
Abstract:Background & AimsVacuole membrane protein 1 (VMP1) is an endoplasmic reticulum (ER) transmembrane protein that regulates the formation of autophagosomes and lipid droplets. Recent evidence suggests that VMP1 plays a critical role in lipoprotein secretion in zebra fish and cultured cells. However, the pathophysiological roles and mechanisms by which VMP1 regulates lipoprotein secretion and lipid accumulation in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are unknown.MethodsLiver-specific and hepatocyte-specific Vmp1 knockout mice as well as Vmp1 knockin mice were generated by crossing Vmp1flox or Vmp1KI mice with albumin Cre mice or by injecting AAV8-TBG-cre, respectively. These mice were characterized for lipid and energy metabolism, metabolomics and transcriptome analyses. Hepatic VMP1 overexpressed mice fed on a NASH diet were also characterized.ResultsHepatocyte-specific deletion of Vmp1 severely impaired VLDL secretion resulting in massive hepatic steatosis, hepatocyte death, inflammation and fibrosis, which are hallmarks of NASH. Mechanistically, loss of Vmp1 led to decreased hepatic levels of phosphatidylcholine and phosphatidylethanolamine as well as the changes of phospholipid composition. Deletion of Vmp1 in mouse liver also led to neutral lipids accumulated in endoplasmic reticulum (ER) bilayer and impaired mitochondrial beta-oxidation. Overexpression of VMP1 ameliorated steatosis in diet-induced NASH by improving VLDL secretion. Importantly, we also show decreased liver VMP1 is associated with NAFLD/NASH in humans.ConclusionsOur results provide novel insights on the role of VMP1 in regulating hepatic phospholipid synthesis and lipoprotein secretion in the pathogenesis of NAFLD/NASH.Lay summaryLack of hepatic VMP1 in mice decreases levels of phospholipids and causes impaired lipoprotein secretion and fatty acid β oxidation resulting in the development of NASH. Decreased VMP1 is associated with human NAFLD/NASH. Overexpression of VMP1 ameliorates diet-induced impaired VLDL secretion and NAFLD in mice.
gastroenterology & hepatology
What problem does this paper attempt to address?